Maplight is a biopharmaceutical company discovering and developing novel therapeutics for patients with disorders of the central nervous system (CNS).

Michael J. Fox Foundation

Cowen Healthcare Investments

5AM Ventures

Novo Holdings

MapLight Therapeutics, Inc.

This April, we also recognize Parkinson's Awareness Month. More than one million people in the United States are diagnosed with this debilitating condition. MapLight is tirelessly working to find another treatment option to serve them. 

Learn more about our Parkinson's research. https://lnkd.in/gjdSh2Q6

MapLight is thrilled to announce that Maria Walker has been appointed to our Board of Directors. Most recently, Maria served as the Founding Partner and Chief Financial Officer at Patient Square Capital, an investment firm dedicated to healthcare. She brings over 30 years of industry experience to the MapLight Board. Learn more via our press release. https://lnkd.in/eJ6QetSi

A reminder that tomorrow (April 4th), we are sponsoring the 11th Annual Autism Science Foundation's Day of Learning. This Autism community event includes families and individuals affected by Autism, advocates, young scientific investigators, and more to participate in TED-style presentations. We look forward to seeing our industry friends and partners in NYC! 

https://lnkd.in/eGPjmxrq

April is here – which means that it is Autism Awareness Month. Did you know that 1 in every 36 U.S. 8-year-olds has Autism Spectrum Disorder? It also affects 1 in every 45 U.S. adults. Throughout the month we'll be sharing facts, resources and events that we're attending that support the Autism community. 

In the meantime, learn more about our work with Autism Spectrum Disorder. https://lnkd.in/gxwYtiwy

Happy National Doctors' Day to all the physicians who dedicate their lives to improving the health and well-being of their patients. At MapLight Therapeutics, we extend our deepest gratitude to the Key Opinion Leaders (KOLs) who collaborate with us across all our research areas. Your insights and expertise are invaluable in our quest to advance the frontiers of medicine. Thank you for your partnership and for the extraordinary care you provide every day. https://lnkd.in/gWZG5wsj

Domain Not Resolving

SSL by Default

Amazon

GoDaddy DNS

AWS Global Accelerator

Tornado

Information Technology

Brandon Abbs

Director, Formulation Development

Culver Cheung

Operations

Emily J.

Senior Director, Project Management

Faith Kreitzer

Senior Director of Information Technology

Jayson Walker

Senior Director of Chemistry

Mark Sylvester

Associate Director

Patsy Casalino

Business Management

Susmita Chatterjee

Senior Manager, Information Technology

Derick deVera

Emily Yao

Jim Trenkle

Vishwas Setia

Chief Financial Officer

Karoly Nikolich

Co-Founder

Chris Kroeger

Co-Founder & CEO

Karl Deisseroth

Robert Malenka

James Lillie

Chief Scientific Officer

Biopharma Startups

Biopharma Companies

San Francisco Bay Area Life Science Companies

Biotechnology Late Stage Companies With Less Than $50M in Revenue

MapLight Therapeutics offers a platform designed to discover and develop therapeutics for brain disorders. It combines single-cell transcriptomics and optogenetics to identify novel drug targets and develop effective therapies for brain disorders.

Series C - MapLight Therapeutics

Venture Round - MapLight Therapeutics

Grant - MapLight Therapeutics

Palo Alto

California

United States

North America

MapLight Therapeutics

MapLight Therapeutics Taps Morgan Stanley, Jefferies for IPO

MAPLIGHT THERAPEUTICS ANNOUNCES INITIATION OF PHASE 1 CLINICAL TRIAL FOR ML-007/PAC, UNDER ...

MAPLIGHT THERAPEUTICS APPOINTS MARIA WALKER TO BOARD OF DIRECTORS

MAPLIGHT THERAPEUTICS EXPANDS EXECUTIVE LEADERSHIP TEAM WITH APPOINTMENT OF VISHWAS SETIA ...

ML-004 is in Phase 2 trials to assess its effectiveness in treating core symptoms of Autism Spectrum Disorder, focusing on social communication deficits and irritability.

MapLight's therapeutic, targeting M1 and M4 muscarinic receptors, aims to address the positive, negative, and cognitive symptoms of schizophrenia without the side effects of traditional treatments.

MapLight is developing treatments for Alzheimer’s Disease Psychosis, aiming to provide options for symptoms like delusions and hallucinations without the safety liabilities of current off-label medications.

MapLight is exploring novel therapeutic targets for Parkinson’s Disease, supported by grants from The Michael J. Fox Foundation, to address the degeneration of dopamine-producing cells.

MapLight's platform utilizes technologies like optogenetics, STARmap, and transcriptomics to identify and target neural circuits linked to brain disorders, facilitating the development of innovative therapeutics.

Jazz Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative treatments for neurological and psychiatric disorders, including autism spectrum disorder.

Jazz Pharmaceuticals

Yamo Pharmaceuticals is a company dedicated to developing novel therapies for neurological and psychiatric disorders, including autism spectrum disorder.

Yamo Pharmaceuticals

Alvarado Therapeutics is a biopharmaceutical company that focuses on discovering and developing therapeutics for brain disorders, including autism spectrum disorder.

Alvarado Therapeutics

BayBridge Bio is a company involved in the development and commercialization of medications for neurological and psychiatric disorders, including those associated with autism spectrum disorder.

BayBridge Bio

MapLight is a biotech company focused on developing treatments for Autism Spectrum Disorder (ASD).

Chief Executive Officer

Partner

Summer Associate

Resident

Analyst

Associate Director, Biometrics

Senior Manager, Biometrics

Manager, Biostatistics

Senior Project Lead, Biostatistics

Senior Programmer Analyst

Biostatistician / Statistical Programmer

Clinical Programmer Intern

Teaching and Research Assistant

Associate Director, Biometrics at MapLight Therapeutics

Jon Britt

Senior Director, Head of Behavior Pharmacology

Director, In Vivo Biology

Senior Scientist

Scientist, Scientist III

Post doctoral Fellow

Senior Director, In Vivo Biology

Head of Molecular Biology

Postdoctoral Researcher

Head of Molecular Biology at MapLight Therapeutics

Thomas Ray

Chief Discovery Officer

Professor, Depts of Physiology and Neurology

Director, UCSF Neuroscience Graduate Program

Associate Professor, Depts of Physiology and Neurology

Senior Investigator

Associate Investigator

Assistant Investigator

Postdoctoral Fellow

Chief Discovery Officer, MapLight Therapeutics

Anatol Kreitzer

Director Global Supply Chain

Associate Director, Supply Chain 

Senior Supply Chain Manager

Supply Chain Manager

Clinical Drug Supply; Protocol Manager

Clinical Operations Associate

Clinical Monitoring Associate

Clinical Trials Specialist II

Clinical Research Associate (CRA)

Meagan Ruffen

Associate Director, People Operations & Total Rewards

Associate Director, Total Rewards & People Operations

Senior Manager, People Operations

Manager, People Operations

Program Manager, Learning & Success

Senior Human Resources Coordinator

HR Coordinator

Executive Assistant

Administrative Staff

Associate Director, People Operations & Total Rewards at MapLight Therapeutics

Melissa Wheeler

Head of Informatics

Computational Scientist

Teaching Assistant

Research Assistant

Bing Program Manager Intern

Research Assistant at DIAL Laboratory

Jim Notwell

Director of Financial Planning & Analysis

Senior Manager, Financial Planning & Analysis

Manager, Business Transformation Consulting

Financial Planning and Analysis Manager

Director of Financial Planning & Analysis at MapLight Therapeutics

John C.

Associate Director, Global Clinical Supply Chain

Associate Director, Supply Chain

Director, Global Supply Chain at Maplight Therapeutics

Meagan R.

Director, Monitoring Strategy and Execution

Associate Director, Clinical Oversight and Optimization

Sr. Manager, Clinical Oversight & Optimization

Manager, Clinical Monitoring

Sr. Clinical Research Associate

Regional Sr. CRA

Clinical Research Associate

Clinical Manager

Regional Senior Clinical Research Associate

Clinical Research Associate II

Lead Study Coordinator

Clinical Research Assistant

Laboratory Rotations

Proven Subject Matter Expert in Clinical Operations GCP Compliance, Oversight, Clinical Systems Administration, and Process Development and Improvement

Allison Duran

Director, Teams Coach - Team Ecosystem Office

Head of Strategy, Research & Technical Operations

Scientist, Project Manager

Marketing Committee Volunteer

Technology Analyst

Building teams to transform scientific discoveries into novel therapeutics. Strategy - Operations - Alliances - Portfolio Management

Chief Administrative and Accounting Officer

Senior Vice President of Finance

Vice President of Finance

Senior Director, Global Finance & Operations

Senior Manager, External Reporting & Compliance

Assistant Controller

Consultant

Chief Financial Officer at MapLight Therapeutics, Inc.

Jonathan Gillis

Associate Director of GXP QA

Sr QA Manager GXP

QA Manager

Sr. Quality Consultant

QA Consultant

Sr QA Professional

Vanecia Land

Director, Drug Substance

Director, Chemical Development

Associate Director, Chemical Development

Director of Research

Associate Principal Scientist: Process Chemistry

Senior Development Chemist: Innovation

Development Chemist

Post-Doctoral Associate

Curious Scientist, Practical Thinker, Grateful to Work Toward Improving Lives Globally

David Snead

Associate Director, Formulation Development

Principal Scientist, Drug Product Development

Senior Scientist, Drug Product Development

news impact assignment basic	general	May 6, 2024 7:42 AM	e07a78aa
public peers	general	May 6, 2024 7:42 AM	f3421939
news daily refresh	general	Jul 25, 2024 12:00 PM	f436c07e
news processing daily refresh	general	May 21, 2024 2:50 AM	1ed93902
news impact assignment daily	general
news processing basic	general	May 6, 2024 7:42 AM	828bdeed
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	f0501581
crunchbase profile	general	Nov 25, 2024 11:40 AM	ab6eb168
li profile	general	May 6, 2024 7:42 AM	7222fef9
translate crunchbase fundingrounds	general	Nov 25, 2024 2:09 PM	88392bf6
peers	general
news basic	general	May 6, 2024 7:42 AM	07b9a760
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:MAPLIGHTRX

MapLight